U.S. and World Newswire
:
Advertising and Marketing
News
MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
Published: Mon, 10 Mar 2008, 12:50:35 GMT
NEW YORK, N.Y. and LONDON, U.K., March 10 (SEND2PRESS NEWSWIRE) -- Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on meeting the challenges of measuring ROI within the changing dynamics of the pharma industry.
 On Wednesday 26 March 2008, Dr. Bates will deliver a presentation titled, "Are You Up to the Challenge of Measuring ROI in Changing Dynamics of the Pharma Industry?" Bates will challenge the thinking of conference attendees and will expose where ROI goes wrong when used to guide current marketing decisions in a changing dynamic market such as pharma. She will also uncover what opportunities are available in this environment, and what can and should be measured for real results when the environment is dynamic.
Bates has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis. Under Bates' leadership, Eularis issued three related research reports in the past year, including: Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line (www.pharmamarketingroi.com), Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things? (www.pharmaindustrysfe.com), and Ensuring Profitable Patient Adherence Programs by Effectively Using Analytics to Release the Hidden Value Available to the Bottom Line from Adherence (www.patientadherenceroi.com).
The conference will be focused on answering three pivotal areas: "Addressing the Challenges in Measuring ROI" and "Ensuring the Sales and Marketing Functions are Aligned" and "Leveraging Your Brand Potential."
To arrange an interview with Eularis www.eularis.com, please contact Tracey Haefele at +1-646-673-8408 or via email THaefele@Eularis.com.
About Eularis
Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance. Eularis offers pre-launch analytics, marketing mix modeling, portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Eularis has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others.
For more information about Eularis, visit www.eularis.com.
All trademarks acknowledged.
 View This Press Release in Japanese (PDF)
NEWS SOURCE: Eularis
Send2Press® is the originating wire service for this story.
» Read More Advertising and Marketing News
» Other Send2Press Industry News by Category
More Information and Media Contact:
For questions about this story, contact the news source:
»
Click Here for Contact Information
THE CONTENT OF THE ABOVE NEWS STORY WAS PROVIDED BY THE NEWS SOURCE WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT SEND2PRESS (THIS WEBSITE).
O T H E R R E S O U R C E S
T E R M S O F U S E
This article is Copr. © 1983-2008 Neotrope / Send2Press. Reproduction of this news article version requires written authorization. You may freely link to this article. Journalists (see the section "Journalist Resources" above) may use orig. news release as the basis for an article.
News Websites may republish the "news release" text version linked to above under "Journalist Resources" except must retain "Send2Press Newswire" as the source of this news if used verbatim. Websites which offer/sell PR or newswire services, or web promotion services, or "splogs" may NOT reprint our content in ANY form. Send2Press Newswire is a service mark of, and "Send2Press" is a registered trademark of, Neotrope. Creative Commons - Some Rights Reserved (3.0) - Attribution Required.
DISCLAIMER: the above article is believed accurate but not guaranteed, and is based on business news supplied by the source (Eularis). The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope or Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.
REFERENCES: MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London, Dr. Andree Bates, pharmaceutical analytics company Eularis, pharma marketing teams, Measuring Marketing ROI in Pharma Conference, research reports, Ensuring Profitable Patient Adherence Programs, Mar 10, 2008.
VIEWED BY MEDIA (and public): 580 times (1 today, 16 this week,
75 this month, 580 this year)
| Eularis to Address Marketing Return at Japanese Pharmaceutical Marketing Excellence Conference |
| STG Launches Media Campaign for the First DNA Paternity Test in Major Retail Stores |
| Neotrope Selected to Provide Internet Marketing Solutions for Creative Commercial Financing Firm, Lease With Crystal |
| Eularis to Address Making the Right Research Decision for ROI |
| BidaBingers Sell Faster with Real Estate Auctions |
| Finally, a Medium Worthy of Your 'Green' Marketing Message |
| Long Term Care Insurance Agency Wins 4 'Marketing Excellence' Awards |
| TechGenii CEO Featured as Digital Media Expert in Entrepreneur's Influencers Issue |
| STG Media Corp. Combines Forces with Internet Solutions Provider Salient Digital, Inc. to Form STG Interactive |
| A Million Kids Read Kidsville News! |
| Inventis Launches Robust Executive Career Marketing Service and Tax-Free Solar Energy Opportunity |
| MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London |
| Myo-Med, Tom Brady and STG Media Corp. Team Up to Jump Start Myo-Med's 2008 Advertising Campaign |
| Racing Through Recession: Brand Lessons from The Daytona 500 |
| STG Media Corp and STG Retail Direct Push the Limits on National Beverage Distribution, by Creating a Drink that Has all the Ladies Talking |
| Stephen King Joins LocaModa via Facebook, Monster and Dotomi |
| Passers-by and Web Users Interact with Times Square Digital Screen |
| TenthGate International, Inc. Retains Sandler Communications |
| Neotrope Selected to Provide Internet Marketing Solutions for Direct Mail Firm, The Ballantine Corporation |
| 1-800-SKI VAIL Validated by The Court of Appeals in Trademark Lawsuit Against Vail Ski Area |
| Google, Yahoo! 'Personal Trainers' Strengthen Digital Delts, Partner with Saatchi & Saatchi Healthcare Communications Group Teams in Tech Circuit Training |
| JSM Music Celebrates Its Top 10 Super Bowl Ad Featuring Justin Timberlake |
| Haywood County Tomatoes Travel the Internet |
| Ballantine Corporation Releases Direct Mail Format Report |
| ROIonline Announces Business Deal with EUROPAGES and Kompass |
» View All News Channels
» Press Release Services
» Send2Press Home Page
|
|
|
|
|
Subscribe in a reader
PLAIN TEXT FORMAT (UTF-8)
PDF FORMAT
